Cholestatic liver diseases: new strategies for prevention and treatment of hepatobiliary and cholestatic diseases.
Based on proceedings of the 75th Falk Symposium in Maastricht (The Netherlands) on cholestasis and gallstone disease, recent developments in this field are highlighted. New ideas on bile and gallstone formation as well as effect of cholestasis on the handling of bilirubin and bile salts are presented. Special attention is paid to the latest data concerning ductopenic liver diseases with emphasis on therapy with ursodeoxycholic acid (UDCA).
van de Meeberg
P C
PC
Department of Gastroenterology, University Hospital Utrecht, Netherlands.
Wolfhagen
F H
FH
van Erpecum
K J
KJ
van Berge Henegouwen
G P
GP
D001646:Bile / Q000502:physiology; D001660:Biliary Tract Diseases / Q000517:prevention & control / Q000628:therapy; D015209:Cholangitis, Sclerosing / Q000150:complications / Q000628:therapy; D002769:Cholelithiasis / Q000503:physiopathology / Q000628:therapy; D002779:Cholestasis / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000628:therapy